You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

LOMU+BEVA

Cancer Type: Central Nervous System      Intent: Palliative
Regimen Category: Evidence-informed
Drugs Used:
bevacizumab (Unfunded)
Funding:
ODB - General Benefit
    lomustine

You might also be interested in